(RTTNews) - Johnson & Johnson (JNJ) disclosed in a regulatory filing that it set aside a $3.9 billion to cover verdict against the company over its Baby Powder and other settlements.
The company reserved some of the money for a 2018 Missouri verdict for about 20 women who alleged that decades of daily use of Johnson & Johnson's asbestos-laden talcum powder products caused their ovarian cancer.
A Missouri appeals court in June 2020 reduced a damages award against Johnson & Johnson to about $2.12 billion from $4.69 billion.
The Missouri Supreme Court in November 2020 refused to consider J&J's arguments that the reduced verdict was flawed and excessive. The company is now asking the U.S. Supreme Court to throw the award out entirely.
In May 2020, Johnson & Johnson said it would stop selling its talc-based Johnson's Baby Powder in the United States and Canada, as demand fell amid mounting consumers lawsuits that claimed the talc products caused cancer.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
